One example is c-Myc-driven B-cell lymphoma, in which the overexpression of both Aurora-A and Aurora-B sensitizes cells to pan-Aurora kinase inhibitor treatment [106]. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.